top of page
prof.jpg

Meine Publikationsliste

Diabetes

  1. Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure. Schernthaner G, Brand K, Bailey C Metabolism. 2022 May;130:155160. https://doi.org/10.1016/j.metabol.2022.155160

  2. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, Morin-Papunen L, Schlachter J; CLUE Study Group, Hakkarainen KM, Korhonen P.
    BMJ Open Diabetes Res Care. 2022 Jan;10(1):e002363. https://doi.org/10.1136/bmjdrc-2021-002363

  3. Mechanisms of action of metformin with special reference to cardiovascular protection. Zilov AV, Abdelaziz SI, AlShammary A, Al Zahrani A, Amir A, Assaad Khalil SH, Brand K, Elkafrawy N, Hassoun AAK, Jahed A, Jarrah N, Mrabeti S, Paruk I.Diabetes Metab Res Rev. 2019 Oct;35(7):e3173. https://doi.org/10.1002/dmrr.3173

  4. Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246. Brand K.Diabetes Care. 2020 Oct;43(10):e157-e158. https://doi.org/10.2337/dc20-0993

  5. Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder. Neven E, Vervaet B, Brand K, Gottwald-Hostalek U, Opdebeeck B, De Maré A, Verhulst A, Lalau JD, Kamel S, De Broe ME, D'Haese PC.Kidney Int. 2018 Jul;94(1):102-113. https://doi.org.10.1016/j.kint.2018.01.027

im Rahmen der Promotion

  1. Entwicklung und Charakterisierung monoklonaler Antikörper zum Nachweis von Furanolabdanditerpenen und Triterpenen vom Oleanoltyp. Dissertation, Bonn 2002

  2. Furanic labdane diterpenes from Marrubium vulgare L. (Lamiaceae) - investigation of analgesic effects. Brand, K., Schlüter, W., Schlemper, V., Cechinel-Filho, V. and Knöss, W. Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 1, 1999, 54

  3. Antinociceptive effect of furanic labdane diterpenes Brand, K., Zampirollo, J., Schlemper, V., Cechinel-Vilho, V. and Knöss, W. Arch. Pharm. Pharm. Med. Chem. 331, Suppl. 2 1999, 6

  4. Monoclonal Antibodies: Tools in Isoprenois research Brand, K., Zündorf, I.,Dingermann, T., Knöss, W. Arch. Pharm. Pharm. Med. Chem. 334, Suppl. 2001

bottom of page